Oxford University researchers and local company work together to accelerate HIV vaccine research
17-Jun-2005 -
Scientists in Oxford, developing a vaccine for HIV, hope to be able to accelerate the testing of the vaccine thanks to a donation of vital research reagents by a local Oxford company. ProImmune Ltd has donated reagents based on its Pro5® MHC Pentamer technology to researchers at the MRC Human ...
clinical trials
diseases
immunology
+2